Abstract
The asthma animal model is still the only system that is available for modelling in vivo processes of human disease since for obvious ethical reasons these experiments are not possible in humans. However, there is a marked discrepancy between numerous successful studies in animals and very few rather disappointing clinical trials in patients. The current available models are usually uniform models of an acute asthmatic attack in adult animals, which do not spontaneously develop asthma. Major anatomical differences exist between human and animal airways and comparable lung function measurements are very difficult or impossible. The main reason why simplistic animal models may be inadequate lies probably in the diversity that exists within the different phenotypes of human asthma. Whereas progress is made to develop chronic asthma models with signs of airway remodelling, severe asthma and the role of small airways is still poorly reflected in current animal models.
Keywords: Animal model, asthma, severe asthma, small airways, airway remodelling
Current Drug Targets
Title: Animal Models for Human Asthma: The Perspective of a Clinician
Volume: 9 Issue: 6
Author(s): Norbert Krug and Klaus F. Rabe
Affiliation:
Keywords: Animal model, asthma, severe asthma, small airways, airway remodelling
Abstract: The asthma animal model is still the only system that is available for modelling in vivo processes of human disease since for obvious ethical reasons these experiments are not possible in humans. However, there is a marked discrepancy between numerous successful studies in animals and very few rather disappointing clinical trials in patients. The current available models are usually uniform models of an acute asthmatic attack in adult animals, which do not spontaneously develop asthma. Major anatomical differences exist between human and animal airways and comparable lung function measurements are very difficult or impossible. The main reason why simplistic animal models may be inadequate lies probably in the diversity that exists within the different phenotypes of human asthma. Whereas progress is made to develop chronic asthma models with signs of airway remodelling, severe asthma and the role of small airways is still poorly reflected in current animal models.
Export Options
About this article
Cite this article as:
Krug Norbert and Rabe F. Klaus, Animal Models for Human Asthma: The Perspective of a Clinician, Current Drug Targets 2008; 9 (6) . https://dx.doi.org/10.2174/138945008784533598
DOI https://dx.doi.org/10.2174/138945008784533598 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Enhancement by Nanogold of the Efficacy of a Light-Activated Antimicrobial Coating
Current Nanoscience Drug-Induced QTc Interval Prolongation: A Multicenter Study to Detect Drugs and Clinical Factors Involved in Every Day Practice
Current Drug Safety Sepsis: Links between Pathogen Sensing and Organ Damage
Current Pharmaceutical Design Review of Vital Signs Monitoring Systems – Patient’s Acceptability, Issues and Challenges
Neuroscience and Biomedical Engineering (Discontinued) Autoantibody Reaction to Myelin Basic Protein by Plasma Parvovirus B19 IgG in MS Patients
Protein & Peptide Letters Natural Compounds Therapeutic Features in Brain Disorders by Experimental, Bioinformatics and Cheminformatics Methods
Current Medicinal Chemistry Personalized Medicine and Molecular Diagnostics for Obesity: Metabolic Systems Reconstruction and Gut Microbiome Biomarkers
Current Pharmacogenomics and Personalized Medicine Burden of Bronchiectasis in Indigenous Peoples - How Can it be Improved?
Current Pediatric Reviews Interleukin-17A: A Potential Therapeutic Target in Chronic Lung Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets The Role of Alpha1-Antitrypsin Deficiency in Respiratory Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Inhaled Corticosteroids in COPD: Pros and Cons
Current Drug Targets Tissue Distribution and Pharmacodynamics: A Complicated Relationship
Current Drug Metabolism VIP in Neurological Diseases: More Than A Neuropeptide
Endocrine, Metabolic & Immune Disorders - Drug Targets Advances in Encoding of Colloids for Combinatorial Libraries: Applications in Genomics, Proteomics and Drug Discovery
Current Pharmaceutical Biotechnology Sex Steroid Hormone Effects in Normal and Pathologic Conditions in Lung Physiology
Mini-Reviews in Medicinal Chemistry G-Protein Coupled Receptor Resensitization - Appreciating the Balancing Act of Receptor Function
Current Molecular Pharmacology Eosinophilopoiesis at the Cross-Roads of Research on Development, Immunity and Drug Discovery
Current Medicinal Chemistry Lung Volume Reduction in Patients with COPD: Physiological and Clinical Implications
Current Respiratory Medicine Reviews Vitamin D Biology in Heart Failure: Molecular Mechanisms and Systematic Review
Current Drug Targets Asthma Self-Management for School-Age Children
Current Pediatric Reviews